MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 15, 2008; DOI: 10.1124/mol.108.045948


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.045948v1
74/1/195    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, B. W
Right arrow Articles by Hinkle, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, B. W
Right arrow Articles by Hinkle, P.


Received for publication January 31, 2008.
Revised April 14, 2008.
Accepted for publication April 15, 2008.

ARRESTIN BINDS TO DIFFERENT PHOSPHORYLATED REGIONS OF THE TRH RECEPTOR WITH DISTINCT FUNCTIONAL CONSEQUENCES

Brian W Jones 1 Patricia Hinkle 1*

1 University of Rochester Medical Center

* Address correspondence to: E-mail: patricia_hinkle{at}urmc.rochester.edu

Abstract

Arrestin binding to agonist-occupied phosphorylated G protein-coupled receptors typically increases the affinity of agonist binding, increases resistance of receptor-bound agonist to removal with high acid/salt buffer, and leads to receptor desensitization and internalization. We tested whether TRH receptors lacking phosphosites in the C-terminal tail could form stable and functional complexes with arrestin. Fibroblasts from mice lacking arrestins 2 and 3 were used to distinguish between arrestin-dependent and -independent effects. Arrestin did not promote internalization or desensitization of a receptor that had key Ser/Thr phosphosites mutated to Ala (4Ala receptor). Nevertheless, arrestin greatly increased acid/salt resistance and the affinity of 4Ala receptor for TRH. Truncation of 4Ala receptor just distal to the key phosphosites (4AlaStop receptor) abolished arrestin-dependent acid/salt resistance but not the effect of arrestin on agonist affinity. Arrestin formed stable complexes with activated wildtype and 4Ala receptors, but not with 4AlaStop receptor, as measured by translocation of arrestin-GFP to the plasma membrane or chemical cross-linking. An arrestin mutant that does not interact with clathrin and AP2 did not internalize receptor but still promoted high affinity TRH binding, acid/salt resistance, and desensitization. A sterically restricted arrestin mutant did not cause receptor internalization or desensitization, but did promote acid/salt resistance and high agonist affinity. The results demonstrate that arrestin binds to proximal or distal phosphosites in the receptor tail. Arrestin binding at either site causes increased agonist affinity and acid/salt resistance, but only the proximal phosphosites evoke the necessary conformational changes in arrestin for receptor desensitization and internalization.


Key words: Thyrotropin/TRH, Gq/11 family, Receptor synthesis/trafficking, Desensitization/uncoupling, Sequestration/Internalization, GRKs, barrestins, Phosphorylation/Dephosphorylation


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
V. V. Gurevich and E. V. Gurevich
Rich Tapestry of G Protein-Coupled Receptor Signaling and Regulatory Mechanisms
Mol. Pharmacol., August 1, 2008; 74(2): 312 - 316.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics